Heart Failure Registry

Veradigm’s Heart Failure Registry

Cardiovascular disease (CVD) remains one of the most prevalent — and urgent — health issues in the world.

In the United States, nearly 6.7 million adults 20 years old or older have heart failure. Heart failure cost the nation an estimated $30.7 billion in 2012. This total includes the cost of health care services, medicines to treat heart failure, and missed days of work.¹

Veradigm Cardiology Registries, operated in collaboration with the American College of Cardiology, encompass cardiology’s largest outpatient quality improvement registry.

Veradigm’s disease registries leverage both structured and unstructured data to provide precise insights into disease patterns, treatment outcomes, and patient care. These registries enable deep, targeted research that drives innovation and enhances real-world clinical insights.

Registry data provides information on diverse patient populations and rich clinical insights.

Key Heart Failure Publications

• Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology Registry
• Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction
• Comparison of machine learning algorithms for predicting hospital readmissions and worsening heart failure events in patients with heart failure with reduced ejection fraction: modeling study

Explore All Veradigm Clinical Data Registry Publications

1. https://www.cdc.gov/heart-disease/about/heart-failure.html